Evidence map›Paper›PMID 36228909›Full record

ArticleThe American journal of tropical medicine and hygiene2022

Multidisciplinary Investigations of Sustained Malaria Transmission in the Greater Mekong Subregion.

Liwang Cui, Jetsumon Sattabongkot, Pyae Linn Aung, Awtum Brashear, Yaming Cao, Jaranit Kaewkungwal, Amnat Khamsiriwatchara, Myat Phone Kyaw, Saranath Lawpoolsri, Lynette Menezes and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Epidemiology of malaria and leishmaniasis in Thailand (2004-2025): A systematic review.Current research in parasitology & vector-borne diseases · 2026
    Review
  4. Efficacy of Primaquine for the Radical Cure of Plasmodium vivax Malaria in Northeast Myanmar and the Impact of Cytochrome P450 2D6 Genotypes.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 7 institutions in 4 countries.

Liwang CuiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Jetsumon SattabongkotMahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
Pyae Linn AungMyanmar Health Network Organization, Yangon, Myanmar.
Awtum BrashearDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Yaming CaoDepartment of Immunology, China Medical University, Shenyang, China.
Jaranit KaewkungwalDepartment of Tropical Hygiene, Mahidol University, Bangkok, Thailand.
Amnat KhamsiriwatcharaDepartment of Tropical Hygiene, Mahidol University, Bangkok, Thailand.
Myat Phone KyawMyanmar Health Network Organization, Yangon, Myanmar.
Saranath LawpoolsriDepartment of Tropical Hygiene, Mahidol University, Bangkok, Thailand.
Lynette MenezesDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Jun MiaoDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Wang NguitragoolMahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
Daniel ParkerDepartment of Epidemiology, University of California at Irvine, Irvine, California.
Suparat PhuanukoonnonMahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
Wanlapa RoobsoongMahidol Vivax Research Unit, Mahidol University, Bangkok, Thailand.
Faiza SiddiquiDepartment of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida.
Myat Thu SoeMyanmar Health Network Organization, Yangon, Myanmar.
Patchara SriwichaiDepartment of Medical Entomology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Zhaoqing YangDepartment of Pathogen Biology and Immunology, Kunming Medical University, Kunming, China.
Yan ZhaoDepartment of Immunology, China Medical University, Shenyang, China.
Daibin ZhongProgram in Public Health, University of California at Irvine, Irvine, California.
Mahidol University · THUniversity of South Florida · USMyanmar Oxford Clinical Research Unit · MMChina Medical University · CNUniversity of California, Irvine · USKunming Medical University · CNMahidol Oxford Tropical Medicine Research Unit · TH

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
NIAID NIH HHS U19 AI089672
6 · The paper itself

Abstract

In the course of malaria elimination in the Greater Mekong Subregion (GMS), malaria epidemiology has experienced drastic spatiotemporal changes with residual transmission concentrated along international borders and the rising predominance of Plasmodium vivax. The emergence of Plasmodium falciparum parasites resistant to artemisinin and partner drugs renders artemisinin-based combination therapies less effective while the potential spread of multidrug-resistant parasites elicits concern. Vector behavioral changes and insecticide resistance have reduced the effectiveness of core vector control measures. In recognition of these problems, the Southeast Asian International Center of Excellence for Malaria Research (ICEMR) has been conducting multidisciplinary research to determine how human migration, antimalarial drug resistance, vector behavior, and insecticide resistance sustain malaria transmission at international borders. These efforts allow us to comprehensively understand the ecology of border malaria transmission and develop population genomics tools to identify and track parasite introduction. In addition to employing in vivo, in vitro, and molecular approaches to monitor the emergence and spread of drug-resistant parasites, we also use genomic and genetic methods to reveal novel mechanisms of antimalarial drug resistance of parasites. We also use omics and population genetics approaches to study insecticide resistance in malaria vectors and identify changes in mosquito community structure, vectorial potential, and seasonal dynamics. Collectively, the scientific findings from the ICEMR research activities offer a systematic view of the factors sustaining residual malaria transmission and identify potential solutions to these problems to accelerate malaria elimination in the GMS.

Indexed as

AntimalarialsArtemisininsMalariaMalaria, FalciparumAnimalsDrug ResistanceHumansMosquito VectorsPlasmodium falciparumAntimalarialsArtemisinins

Identifiers

PMID36228909
PMCPMC9662214
OpenAlexW4306154210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.